Stock ACHV ACHIEVE LIFE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Achieve Life Sciences, Inc.

Equities

ACHV

US0044685008

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 01:30:00 02/07/2024 am IST 		5-day change 1st Jan Change
4.78 USD +1.70% Intraday chart for Achieve Life Sciences, Inc. +1.06% +16.02%
01/07 Achieve Life Sciences Added to Russell 3000, Microcap Indexes MT
29/05 Achieve Life Sciences, Inc. Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes CI

Business Summary

Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of action that is both agonistic and antagonistic. Cytisinicline is a partial agonist that binds with high affinity to the alpha-4 beta-2, nicotinic acetylcholine receptors in the brain. Through its dual-acting partial agonist/partial antagonist activity, cytisinicline helps reduce nicotine cravings, withdrawal symptoms and reward and satisfaction associated with smoking. It is developing cytisinicline as an aid to smoking cessation and treatment for nicotine addiction to address the limitations of both prescription drugs and of over the counter (OTC) products.

Number of employees: 22

Managers

Managers TitleAgeSince
John Bencich CEO
 Chief Executive Officer 47 01/14/01
Richard Stewart CHM
 Chairman 65 01/15/01
Cindy Jacobs PSD
 President 66 01/08/01
Anthony Clarke CTO
 Chief Tech/Sci/R&D Officer 68 01/15/01
Jerry Wan AUD
 Comptroller/Controller/Auditor 42 01/17/01
Jaime Xinos PRN
 Corporate Officer/Principal - 01/17/01

Members of the board

Members of the board TitleAgeSince
Vaughn Himes BRD
 Director/Board Member 63 14/22/14
Thomas King BRD
 Director/Board Member 69 29/23/29
Cindy Jacobs PSD
 President 66 01/08/01
Anthony Clarke CTO
 Chief Tech/Sci/R&D Officer 68 01/15/01
John Bencich CEO
 Chief Executive Officer 47 01/14/01
Stuart Duty BRD
 Director/Board Member 59 29/23/29
Richard Stewart CHM
 Chairman 65 01/15/01
Bridget Martell BRD
 Director/Board Member 58 15/20/15
Thomas Sellig BRD
 Director/Board Member 57 29/23/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 34,341,303 31,013,635 ( 90.31 %) 0 90.31 %

Shareholders

NameEquities%Valuation
Franklin Advisers, Inc.
17.37 %
5,964,088 17.37 % 31 M $
Dialectic Geronimo SPV LLC
10.17 %
3,494,000 10.17 % 18 M $
Propel Bio Management LLC
7.143 %
2,453,092 7.143 % 13 M $
Iii Patrick J Callahan
4.450 %
1,528,293 4.450 % 8 M $
Sofinnova Investments, Inc.
4.421 %
1,518,230 4.421 % 8 M $
Contrarian Capital Management LLC
3.841 %
1,318,918 3.841 % 7 M $
Vanguard Global Advisers LLC
2.762 %
948,441 2.762 % 5 M $
Adar1 Capital Management LLC
2.548 %
875,000 2.548 % 5 M $
Altium Capital Management LP
2.433 %
835,470 2.433 % 4 M $
Nantahala Capital Management LLC
1.904 %
654,000 1.904 % 3 M $

Company contact information

Achieve Life Sciences, Inc.

1040 West Georgia Street Suite 1030

V6E 4H1, Vancouver

+

http://www.achievelifesciences.com
address Achieve Life Sciences, Inc.(ACHV)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.78 USD
Average target price
18 USD
Spread / Average Target
+276.57%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ACHIEVE LIFE SCIENCES, INC. Stock Achieve Life Sciences, Inc.
+16.02% 16Cr
MODERNA, INC. Stock Moderna, Inc.
+16.59% 4.44TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-9.89% 3.8TCr
LONZA GROUP AG Stock Lonza Group AG
+36.67% 3.78TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+27.12% 3.08TCr
CELLTRION, INC. Stock Celltrion, Inc.
-8.64% 2.74TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.81% 2.62TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+45.08% 1.42TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.85% 1.26TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-7.19% 1.13TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ACHV Stock
  4. Company Achieve Life Sciences, Inc.